• Wed, August 8, 2018

Stephen Willey Maintained (XENE) at Strong Buy with Increased Target to $15 on, Aug 8th, 2018

Stephen Willey of Stifel, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Increased Target from $9 to $15 on, Aug 8th, 2018.

Stephen, nor any peers, have made any analyst calls on XENE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications